Summary of Product Characteristics (Bydureon)
Making some simple lifestyle changes can help you lower your risk and stay on track with your health goals
Semaglutide, a GLP-1 Receptor Agonist, can be a game changer for those of us with diabetes yes, even type 1s, although it is off-label currently
In higher doses, semaglutide is approved under the brand name Wegovy for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related health condition, such as hypertension, dyslipidemia, or obstructive sleep apnea
Common adverse effects include urinary and genital infections and there have been two FDA warnings about the risks of ketoacidosis since its approval
Common side effects from semaglutide The most frequently reported side effects of semaglutide are gastrointestinal in nature